Prospective Regional Epilepsy Database

Condition(s) studied

Investigational drug(s) / intervention(s)

Seizure status: We will collect information on first seizure ever, last seizure ever, number of seizure in last two months.

Tests: We will collect results from imaging, electroencephalogram, and laboratory tests.

Epilepsy: We will collect information on risk factors of epilepsy, cause of epilepsy, epilepsy type/syndrome, medications tried, if the epilepsy is drug resistent, side effects of antiepileptic drugs.

Demographics and psychosocial: We will collect information on age, sex, date of death if applicable, marital status, education level, income type, driving status, employment, benefits, sick leave, number of household members.

Health care: We will collect information on received health care; visit dates, caregiver, dispensation dates of antiepileptic drugs

Study summary

PREDICT is an observational study following adults with an unprovoked seizure or epilepsy in the health care region of western Sweden. The objective is to identify biomarkers and/or genetic predisposition of relevance for diagnosis and/or treatment of epilepsy and study the long-term prognosis and consequences of epilepsy.

Eligibility

Primary outcome measure(s)

• epilepsy — baseline and years 1,2,3,4,5,6,7,8,9,10
  more than one seizure after first seizure
• seizure status — baseline and years 1,2,3,4,5,6,7,8,9,10
  the number of seizures in last two months and overall
• drug resistant epilepsy — baseline and years 1,2,3,4,5,6,7,8,9,10
  epilepsy that has not responded to two antiepileptic drugs
• severe side effects of antiepileptic drug — baseline and years 1,2,3,4,5,6,7,8,9,10
• psychosocial outcomes — baseline and years 1,2,3,4,5,6,7,8,9,10
  employment, marital status, income, sick leave

Trial sites (3)

More Sahlgrenska University Hospital trials in Sweden

Other trials for the same condition